Daclatasvir Side Effects

Like all medications, Daclatasvir can cause side effects. Most people do not experience serious adverse effects, but it is important to know what to look for and when to seek medical care.

Common Side Effects

→Nausea and GI discomfort
→Headache
→Fatigue
→Renal effects (acyclovir — adequate hydration required)

Serious Side Effects

→Renal toxicity (acyclovir, tenofovir)
→Neurological effects (high-dose acyclovir)
→Bone marrow suppression (ganciclovir)
→Severe skin reactions

When to Seek Medical Care

→Significant decrease in urine output
→Severe headache, confusion, or seizures
→Unusual bruising or pallor

Safety Note

If you experience any unexpected or concerning symptoms while taking Daclatasvir, contact your doctor or pharmacist. Do not stop taking Daclatasvir without medical advice unless you experience a serious adverse reaction.

Frequently Asked Questions

Are side effects from Daclatasvir common?

Most patients tolerate Daclatasvir well at therapeutic doses. Common side effects are usually mild and often improve after the first few weeks. Serious side effects are less common but should be reported immediately.

What should I do if I experience side effects from Daclatasvir?

Mild side effects: discuss with your pharmacist, as many resolve spontaneously. Serious side effects: seek medical care immediately and contact your prescriber. Do not stop Daclatasvir abruptly for long-term conditions without medical advice.

More About Daclatasvir

Dosage & Administration

Drug Interactions

Warnings & Precautions

← Back to Daclatasvir Overview

Have Questions About Daclatasvir?

Describe your symptoms and concerns and get a structured clinical assessment — possible causes, red flags, and recommended next steps.

Start Free AI Analysis →

Medical Disclaimer: This drug reference is provided for informational purposes only and is not a substitute for professional medical advice. Always consult your physician or pharmacist before changing your medication. Information reviewed by the vHospital Editorial Team · Sources: WHO, BNF, FDA prescribing information.